Loading stock data…
EVAX
$4.50+0.09 (+1.93%)
Market ClosedLast close May 1
Evaxion A/S, a clinical-stage biotech company, develops artificial intelligence-powered immunology vaccines.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Evaxion A/S in the Healthcare sector is trading at $4.50. The stock is currently 63% below its 52-week high of $12.15, remaining 4.8% above its 200-day moving average. Technical signals show neutral RSI of 62 and bullish MACD crossover, explaining why EVAX maintains its current momentum and trend strength. The Whystock Score of 40/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Neutral momentum (RSI 62) — price action in range
Long-term trend bullish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$4.50
Potential Upside
5%
Whystock Fair Value$4.72
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Fundamentals
Evaxion A/S, a clinical-stage biotech company, develops artificial intelligence-powered immunology vaccines. The company develops EVX-01, which is in phase 2 global multi-center clinical trial for the treatment of advanced melanoma; EVX-03, DNA-based...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$35.45M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
Defensive asset. Lower volatility than the S&P 500.
0.20
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-45.23%
Volume
Today's trading volume
30,115
Recent News
European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading
European equities traded in the US as American depositary receipts were rising late Friday morning,
European Equities Traded in the US as American Depositary Receipts Edge Higher in Wednesday Trading
European equities traded in the US as American depositary receipts were higher late Wednesday mornin
European Equities Traded in the US as American Depositary Receipts Sharply Lower in Tuesday Trading
European equities traded in the US as American depositary receipts were falling sharply late Tuesday
European Equities Traded in the US as American Depositary Receipts Declining in Thursday Trading
European equities traded in the US as American depositary receipts were trending lower late Thursday
European Equities Traded in the US as ADRs Rise in Tuesday Trading
European equities traded in the US as American depositary receipts rose late Tuesday morning with th